Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
Indian TB cases 'can't be cured'

Tuberculosis which appears to be totally resistant to antibiotic treatment has been reported for the first time by Indian doctors.

Published
17 January 2012
From
BBC Health
Totally Drug Resistant TB strain turns up in patients in India

Doctors at the Hinduja National Hospital and Research Centre in Mumbai, India, are reporting on a strain of tuberculosis (TB) emerging among patients that is resistant to all first- and second-line drugs used to treat the bacterial infection. At least twelve patients have been identified so far.

Published
11 January 2012
From
Science Speaks
Deadly tuberculosis stalks Europe

The WHO's Regional Office for Europe recently released a report that warned about the spread of the hard-to-treat MDR-TB into all of Europe, making the case that the relatively wealthy capitals of the West faced the grave danger of a much higher number of cases if the entire region did not move quickly to put in place effective control measures.

Published
03 January 2012
From
Global Post
TB leads to poorer CD4 cell gains after starting HIV treatment

Tuberculosis (TB) is associated with an impaired immune response to antiretroviral therapy, according to Italian research published in the online edition of Clinical Infectious Diseases. The study involved

Published
23 December 2011
By
Michael Carter
New Shorter Treatment for Latent TB Not Recommended for HIV+ People on ART

Expert panels that put together the Department of Health and Human Services antiretroviral therapy (ART) guidelines have advised that the shorter and simpler combination regimen for latent tuberculosis (TB) recently recommended by the Centers for Disease Control and Prevention (CDC) is not suitable for people being treated for HIV.

Published
22 December 2011
From
HIVandHepatitis.com
New Tests for Latent TB May Be Unreliable in Pregnancy

A new report warns against using interferon gamma release assays (IGRA) to look for tuberculosis in pregnant women.

Published
22 December 2011
From
Medscape (requires free registration)
Molecular Test for TB Works Best Combined With Sputum Smear

A rapid molecular test for tuberculosis (TB) endorsed last year by the World Health Organization turns out to be most accurate and economic when it's used in combination with sputum microscopy, a new study from South Africa shows.

Published
22 December 2011
From
Medscape (requires free registration)
Short-Term TB Combination as Successful as Isoniazid Therapy

Weekly rifapentine plus isoniazid given under direct supervision for 3 months was as effective in preventing tuberculosis (TB) as 9 months of daily self-administered isoniazid, according to a report published in the December 8 issue of the New England Journal of Medicine.

Published
09 December 2011
From
Medscape (requires free registration)
Discordance among commercially-available diagnostics for latent TB infection

In populations with a low prevalence of tuberculosis, the majority of positives with the three tests commercially available in the US for the diagnosis of TB are false positives, according to a new study.

Published
09 December 2011
From
Eurekalert Inf Dis
CDC releases new 12-dose treatment guidelines for latent TB infection

The Centers for Disease Control and Prevention (CDC) unveiled new guidelines Thursday for the treatment of latent tuberculosis infection (LTBI) in the U.S. with a 12-dose regimen, administered once-weekly under directly observed therapy (DOT). The current regimen requires daily drug administration over nine months, making the new treatment simpler and easier for patients.

Published
08 December 2011
From
Science Speaks

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close